Tag - pharmaceutical

 
Menu
Search
 
April 12, 2025
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICAL

Japan Times
BUSINESS
Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping's administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
JAPAN
Oct 1, 2021
Japan's Takeda says 'human error' caused contamination of Moderna vaccines
Japanese authorities in August suspended the use of three batches of Moderna shots containing 1.63 million doses after being notified of the contamination.
Japan Times
BUSINESS / Companies
Oct 22, 2020
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza.
Japan Times
COMMENTARY / World
Aug 26, 2020
Pharma rivals are fighting COVID-19 together — Why stop there?
Pandemics make for strange bedfellows.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
BUSINESS / Companies
Dec 17, 2018
Taisho said to near $1.6 billion deal for Bristol-Myers unit
Taisho Pharmaceutical Holdings Co. is nearing a deal to buy Bristol-Myers Squibb Co.'s French over-the-counter unit, people familiar with the matter said, as the Japanese drugmaker seeks to boost its overseas presence.
Rugby / RWC Countdown
Sep 19, 2018
Uehara finds common thread between rugby and business
Akira Uehara, the president of longtime rugby national team sponsor Taisho Pharmaceutical Co., Ltd., played in the front row for Keio University's B.Y.B Rugby Football Club in the 1960s.
BUSINESS
Jul 18, 2018
China heart drug sold globally may have had cancer-linked impurity since 2012
A common blood pressure and heart drug manufactured in bulk by a Chinese company and sold worldwide may have contained an impurity linked to cancer since 2012, European regulators said on Tuesday.
Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever.
BUSINESS / Companies
May 23, 2017
Deal for U.S. drugmaker Upsher-Smith Laboratories poised to boost sales for Sawai
For decades, the Sawai family was content to keep the drug business it founded focused on the Japanese market. Now, it is steering the country's second-biggest maker of generic drugs through its first overseas acquisition in its 88-year history.
BUSINESS / Companies
Jan 4, 2017
Ono Pharma's wild 2016 ride cuts stock valuation by ¥1.87 trillion
The rise and fall of Ono Pharmaceutical Co. in 2016 was a tale of two halves, and one drug.
BUSINESS
Nov 1, 2016
Pharma, aerospace industries seek Brexit assurances after Nissan deal
Britain's pharmaceutical and aerospace industries, both big exporters, are stepping up pressure on the government for assurances about their future after last week's post-Brexit deal with carmaker Nissan.
Takayasu’s latest heartbreak makes sumo history
Takayasu during the one-day Annual Sumo Tournament at the Ryogoku Kokugikan in Tokyo on Feb 9, 2020
How police are cracking down on 'scout' sex broker groups
The skyline during sunset in Shinjuku, Tokyo. Japan's new underground criminal groups operate under a highly organized and brutal system.
The man who sent Japan's cherry blossoms out to the world
Masatoshi Asari is one of Japan’s foremost living authorities on cherry trees and their blossoms.
Tokyo cheers Trump’s tariff U-turn with second-biggest market gain ever
U.S. President Donald Trump looks on after signing an executive order in the Oval Office of the White House on Wednesday in Washington.
Berkshire sells $628 million in yen bonds in smallest Japan deal
Berkshire Hathaway concluded a ¥90 billion ($628 million) bond deal on Friday, the smallest yen deal by investor Warren Buffett’s firm since it started tapping the Japanese market in 2019.
How police are cracking down on 'scout' sex broker groups
The skyline during sunset in Shinjuku, Tokyo. Japan's new underground criminal groups operate under a highly organized and brutal system.
Tokyo cheers Trump’s tariff U-turn with second-biggest market gain ever
U.S. President Donald Trump looks on after signing an executive order in the Oval Office of the White House on Wednesday in Washington.
Takayasu’s latest heartbreak makes sumo history
Takayasu during the one-day Annual Sumo Tournament at the Ryogoku Kokugikan in Tokyo on Feb 9, 2020
Who is Ryosei Akazawa, Japan's tariffs negotiator?
Economic revitalization minister Ryosei Akazawa, who Prime Minister Shigeru Ishiba has appointed Japan's tariff negotiator, is one of his closest allies and busiest ministers.
After a tumultuous buildup, a first look at the Osaka Expo
A large statue of Osaka Expo mascot Myaku Myaku sits near the east entrance of the event's venue in Yumeshima island, Osaka, on Wednesday.

Podcast

One of the many entrances to the Kabukicho neighborhood in Tokyo’s Shinjuku Ward.
Kabukicho: Tokyo’s ‘stadium of desire’

Longform

Visitors walk past Sou Fujimoto's Grand Ring, which has been recognized as the largest wooden structure in the world.
Can a World Expo still matter? Japan is about to find out.
By Tomoko Otake

SUSTAINABLE JAPAN

BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)
BOARDING & INTERNATIONAL SCHOOL DAY 2025 (Sunday, April 20)

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER